Sabra Health Care REIT (NASDAQ:SBRA) Price Target Increased to $17.00 by Analysts at Mizuho

Sabra Health Care REIT (NASDAQ:SBRA – Free Report) had its target price boosted by Mizuho from $15.00 to $17.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the real estate investment trust’s stock. Several other equities research analysts also recently issued reports on […]

Leave a Reply

Your email address will not be published.

Previous post RBC Bearings (NASDAQ:ROLL) Earns Hold Rating from Analysts at StockNews.com
Next post Avidity Biosciences (NASDAQ:RNA) Given Overweight Rating at Wells Fargo & Company